NVIDIA and Lilly collaborate to establish a 1 billion USD AI laboratory for drug discovery

NVIDIA and Lilly are investing 1 billion USD to create an AI lab focused on revolutionizing the drug discovery process. The lab will facilitate collaboration between domain scientists and AI engineers to optimize drug development.

This co-innovation lab promotes a continuous learning environment linking experimentation environments while using NVIDIA’s AI tools to enhance molecule discovery and support biotech partnerships.